Cholesterol metabolites and tumor microenvironment: the road towards clinical translation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation
Authors
Keywords
Metabolism, Tumor, Microenvironment, Immune cells, Immunotherapy, NIBIT 2014
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 1, Pages 111-117
Publisher
Springer Nature
Online
2015-12-09
DOI
10.1007/s00262-015-1779-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
- (2015) Colin A. Flaveny et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
- (2015) Juan R. Cubillos-Ruiz et al. CELL
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
- (2015) Fabiola Bovenga et al. Cell Metabolism
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Sterol metabolism controls T H 17 differentiation by generating endogenous RORγ agonists
- (2015) Xiao Hu et al. Nature Chemical Biology
- Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation
- (2014) Nora Pencheva et al. CELL
- Molecular Mechanisms of Cellular Cholesterol Efflux
- (2014) Michael C. Phillips JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolism of stromal and immune cells in health and disease
- (2014) Bart Ghesquière et al. NATURE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Reciprocal Regulation of Hepatic and Adipose Lipogenesis by Liver X Receptors in Obesity and Insulin Resistance
- (2013) Simon W. Beaven et al. Cell Metabolism
- Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice
- (2013) Giuseppe Lo Sasso et al. GASTROENTEROLOGY
- The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
- (2013) Laura Raccosta et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
- (2013) Antoni Ribas et al. NEW ENGLAND JOURNAL OF MEDICINE
- 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
- (2013) E. R. Nelson et al. SCIENCE
- Niemann–Pick C1-Like 1 and cholesterol uptake
- (2012) Li-Juan Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses
- (2012) Nathanael J. Spann et al. CELL
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
- (2012) Nora Pencheva et al. CELL
- Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
- (2012) Ralph J. DeBerardinis et al. CELL
- From tumor cell metabolism to tumor immune escape
- (2012) Martin Villalba et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MAP kinase signaling and inhibition in melanoma
- (2012) R J Sullivan et al. ONCOGENE
- Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
- (2012) Tomas Jakobsson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation
- (2011) Guoliang Cui et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolism, LXR/LXR ligands, and tumor immune escape
- (2011) Vincenzo Russo JOURNAL OF LEUKOCYTE BIOLOGY
- De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
- (2010) E. Rysman et al. CANCER RESEARCH
- Lipid accumulation and dendritic cell dysfunction in cancer
- (2010) Donna L Herber et al. NATURE MEDICINE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The oxysterol receptor LXR inhibits proliferation of human breast cancer cells
- (2009) Lise-Lotte Vedin et al. CARCINOGENESIS
- Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR
- (2009) Noelia A-Gonzalez et al. IMMUNITY
- Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
- (2009) Eduardo J Villablanca et al. NATURE MEDICINE
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
- (2009) Noam Zelcer et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response
- (2008) Steven J. Bensinger et al. CELL
- Cholesterol, Reactive Oxygen Species, and the Formation of Biologically Active Mediators
- (2008) Robert C. Murphy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started